Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Jazz Pharmaceuticals plc JAZZ

Healthcare
Jazz Pharmaceuticals PLC is a biotechnology company. The Company is engaged in developing medicines for people with serious diseases. The Company’s lead marketed products include Xywav (calcium, magnesium, potassium, and sodium oxybates) oral solution, Xyrem (sodium oxybate) oral solution, Epidiolex (cannabidiol) oral solution, Rylaze (asparaginase erwinia chrysanthemi (recombinant)-rywn... see more

Recent & Breaking News (NDAQ:JAZZ)

Jazz Pharmaceuticals Announces Proposed Offering of $500 Million of Exchangeable Senior Notes

PR Newswire August 6, 2014

Jazz Pharmaceuticals Announces Second Quarter 2014 Financial Results And Updated Guidance

PR Newswire August 5, 2014

Jazz Pharmaceuticals Completes Acquisition Of Rights To Defibrotide In The Americas From Sigma-Tau Pharmaceuticals, Inc.

PR Newswire August 5, 2014

Jazz Pharmaceuticals Announces Participation at Canaccord Genuity Conference on August 13

PR Newswire August 4, 2014

CANbridge Life Sciences And EUSA Pharma Form Agreement to Commericalize Caphosol® in China

Business Wire July 28, 2014

Jazz Pharmaceuticals to Report 2014 Second Quarter Financial Results on August 5, 2014

PR Newswire July 22, 2014

Jazz Pharmaceuticals and Concert Pharmaceuticals Provide a Phase 1 Clinical Trial Update on JZP-386

Business Wire July 21, 2014

Jazz Pharmaceuticals Announces Agreement To Acquire Rights To Defibrotide In The Americas From Sigma-Tau Pharmaceuticals, Inc.

PR Newswire July 2, 2014

Investing in the Best Canadian Biotech Stocks

Equities.com June 23, 2014

Jazz Pharmaceuticals Presents JZP-110 Phase 2b Data For The Treatment Of EDS Symptoms In Adults With Narcolepsy

PR Newswire June 2, 2014

Jazz Pharmaceuticals To Present Data On Compound In Sleep Pipeline During APSS Annual SLEEP Meeting

PR Newswire May 27, 2014

Jazz Pharmaceuticals Names Russell J. Cox To Position Of Chief Operating Officer

PR Newswire May 19, 2014

Jazz Pharmaceuticals Announces Participation in Two Investor Conferences

PR Newswire May 13, 2014

Jazz Pharmaceuticals Announces First Quarter 2014 Financial Results

PR Newswire May 8, 2014

Jazz Pharmaceuticals to Report 2014 First Quarter Financial Results on May 8, 2014

PR Newswire April 24, 2014

Jazz Pharmaceuticals And Gentium Announce European Commercial Launch Of First Approved Life-Saving Treatment For Severe Hepatic Veno-Occlusive Disease

PR Newswire March 31, 2014

Ariad Pharmaceuticals (ARIA) Jumps on More Buyout Rumors

Equities.com March 28, 2014

Jazz Pharmaceuticals Announces Participation in Two Investor Conferences in March

PR Newswire February 26, 2014

Jazz Pharmaceuticals Announces Management Change

PR Newswire February 25, 2014

Jazz Pharmaceuticals Announces Full Year And Fourth Quarter 2013 Financial Results

PR Newswire February 25, 2014